Toxicogenomic biomarkers for renal papillary injury in rats

Toxicology

Volumn 303, Issue , 2013, Pages 1-8

  Uehara, Takeki ^a,b,c   Kondo, Chiaki ^a   Morikawa, Yuji ^a,b   Hanafusa, Hiroyuki ^a   Ueda, Seiko ^b   Minowa, Yohsuke ^b   Nakatsu, Noriyuki ^b   Ono, Atsushi ^b   Maruyama, Toshiyuki ^a   Kato, Ikuo ^a   Yamate, Jyoji ^c   Yamada, Hiroshi ^b   Ohno, Yasuo ^d   Urushidani, Tetsuro ^b,e  

^a SHIONOGI AND CO LTD   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c Osaka Prefecture University   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^e DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

Author keywords

Igf1; Lamc2; Papillary injury; Rat; Timp1; Toxicogenomics

Indexed keywords

2 BROMOETHYLAMINE HYDROBROMIDE; ABC TRANSPORTER; ALPHA SYNUCLEIN; BIOLOGICAL MARKER; CERULOPLASMIN; CYTOKERATIN 14; CYTOKERATIN 15; CYTOKERATIN 19; CYTOKERATIN 5; EFENAMIC ACID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTAMINE METHYLTRANSFERASE; KIDNEY INJURY MOLECULE 1; MEROSIN; PHENYLBUTAZONE; PHOSPHOLIPASE A1; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 3; REGUCALCIN; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 12A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; KIDNEY CORTEX; KIDNEY PAPILLA; KIDNEY PAPILLA NECROSIS; MALE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPORT VECTOR MACHINE; TOXICOGENETICS; UPREGULATION; VALIDATION STUDY;

ANIMALS; AREA UNDER CURVE; DOWN-REGULATION; ETHYLAMINES; GENE EXPRESSION PROFILING; GENETIC MARKERS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; KIDNEY DISEASES; KIDNEY MEDULLA; LAMININ; MALE; ORTHO-AMINOBENZOATES; PHENYLBUTAZONE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TOXICOGENETICS; UP-REGULATION;

RATTUS;

EID: 84870575569     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.09.012     Document Type: Article

References (19)

1. Chromek M., Tullus K., Lundahl J., Brauner A. Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes protects them from apoptosis, and blocks their transmigration during inflammation. Infect. Immun. 2004, 72:81-88.
2. Chu P.G., Weiss L.M. Keratin expression in human tissues and neoplasms. Histopathology 2002, 40:403-439.
3. Dieterle F., Sistare F., Goodsaid F., Papaluca M., Ozer J.S., Webb C.P., Baer W., Senagore A., Schipper M.J., Vonderscher J., Sultana S., Gerhold D.L., Phillips J.A., Maurer G., Carl K., Laurie D., Harpur E., Sonee M., Ennulat D., Holder D., Andrews-Cleavenger D., Gu Y.Z., Thompson K.L., Goering P.L., Vidal J.M., Abadie E., Maciulaitis R., Jacobson-Kram D., Defelice A.F., Hausner E.A., Blank M., Thompson A., Harlow P., Throckmorton D., Xiao S., Xu N., Taylor W., Vamvakas S., Flamion B., Lima B.S., Kasper P., Pasanen M., Prasad K., Troth S., Bounous D., Robinson-Gravatt D., Betton G., Davis M.A., Akunda J., McDuffie J.E., Suter L., Obert L., Guffroy M., Pinches M., Jayadev S., Blomme E.A., Beushausen S.A., Barlow V.G., Collins N., Waring J., Honor D., Snook S., Lee J., Rossi P., Walker E., Mattes W. Renal biomarker qualification submission: a dialog between the FDA-EMEA and predictive safety testing consortium. Nat. Biotechnol. 2010, 28:455-462.
4. Hörstrup J.H., Gehrmann M., Schneider B., Plöger A., Froese P., Schirop T., Kampf D., Frei U., Neumann R., Eckardt K.U. Elevation of serum and urine levels of TIMP1 and tenascin in patients with renal disease. Nephrol. Dial. Transplant. 2002, 17:1005-1013.
5. Ichimura T., Bonventre J.V., Bailly V., Wei H., Hession C.A., Cate R.L. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 1998, 273:4135-4142.
6. Ichimura T., Hung C.C., Yang S.A., Stevens J.L., Bonventre J.V. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal Physiol. 2004, 286:F552-F563.
7. Kondo C., Minowa Y., Uehara T., Okuno Y., Nakatsu N., Ono A., Maruyama T., Kato I., Yamate J., Yamada H., Ohno Y., Urushidani T. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database. Toxicology 2009, 265:15-26.
8. Minowa Y., Kondo C., Uehara T., Morikawa Y., Okuno Y., Nakatsu N., Ono A., Maruyama T., Kato I., Yamate J., Yamada H., Ohno Y., Urushidani T. Toxicogenomic multigene biomarker for predicting the future onset of proximal tubular injury in rats. Toxicology 2012, 297:47-56.
9. Moll R. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell. Biochem. 1998, 31:205-262.
10. Moll R., Franke W.W., Schiller D.L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31:11-24.
11. Nguyen N.M., Pulkkinen L., Schlueter J.A., Meneguzzi G., Uitto J., Senior R.M. Lung development in laminin gamma2 deficiency: abnormal tracheal hemidesmosomes with normal branching morphogenesis and epithelial differentiation. Respir. Res. 2006, 16:28.
12. Rogers S.A., Powell-Braxton L., Hammerman M.R. Insulin-like growth factor I regulates renal development in rodents. Dev. Genet. 1999, 24:293-298.
13. Uehara T., Miyoshi T., Tsuchiya N., Masuno K., Okada M., Inoue S., Torii M., Yamate J., Maruyama T. Comparative analysis of gene expression between renal cortex and papilla in nedaplatin-induced nephrotoxicity in rats. Hum. Exp. Toxicol. 2007, 26:767-780.
14. Uehara T., Ono A., Maruyama T., Kato I., Yamada H., Ohno Y., Urushidani T. The Japanese toxicogenomics project: application of toxicogenomics. Mol. Nutr. Food Res. 2010, 54:218-227.
15. Uehara T., Tsuchiya N., Masuda A., Torii M., Nakamura M., Yamate J., Maruyama T. Time course of the change and amelioration of nedaplatin-induced nephrotoxicity in rats. J. Appl. Toxicol. 2008, 28:388-398.
16. Uehara T., Tsuchiya N., Torii M., Yamate J., Maruyama T. Amelioration of nedaplatin-induced nephrotoxicity by continuous infusion in rats. J. Toxicol. Pathol. 2007, 20:141-147.
17. Uehara T., Watanabe H., Itoh F., Inoue S., Koshida H., Nakamura M., Yamate J., Maruyama T. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats. Arch. Toxicol. 2005, 79:451-460.
18. Uehara T., Yamate J., Torii M., Maruyama T. Comparative nephrotoxicity of cisplatin and nedaplatin: mechanisms and histopathological characteristics. J. Toxicol. Pathol. 2011, 24:87-94.
19. Wang E.J., Snyder R.D., Fielden M.R., Smith R.J., Gu Y.Z. Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology 2008, 246:91-100.